Corporate
Jun. 2, 2011
Hybrid Company Performs Well in IPO
South San Francisco-based biofuel company Solazyme Inc. raised $197.6 million in an initial public offering by attracting clean tech investors in a market that is wary of biotech companies.
Daily Journal Staff Writer
South San Francisco-based biofuel developer Solazyme Inc. straddles the line between biotechnology and clean technology, and that may be one reason its initial public offering was successful at a time when biotechnology companies have had a hard time raising money in the public markets.
Davis Polk & Wardwell LLP partner Alan F. Denenberg in Menlo Park represented Solazyme in an IPO Friday that ra...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In